Close Menu
Home » Veracyte, Acerta Pharma Launch Biopharmaceutical Collaboration

Veracyte, Acerta Pharma Launch Biopharmaceutical Collaboration

Jan 08, 2020
|
staff reporter

NEW YORK – Genomic testing firm Veracyte has partnered with Acerta Pharma, the hematology research and development arm of AstraZeneca, to provide genomic information that will support Acerta's development of oncology therapeutics. 

Financial and other terms were not disclosed. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb
05
Featured Webinar

Development of a Novel Multiplex Assay: A Partnership Case Study

Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.

Feb
26
Featured Webinar

Transformation of the Lab to Fight Genetic Illnesses in the Amish and Mennonite Populations

Sponsored by
Autogen

This webinar will explain how the Clinic for Special Children in Strasburg, Pennsylvania, has transformed its DNA workflows to improve the diagnosis and treatment of genetic illnesses that are prevalent in the pediatric population of its community.

Feb
27
Featured Webinar

Digital PCR Method Development for Accurate Quantification of Copy Number Variations

Sponsored by
Stilla

Since the publication of the “The Digital MIQE Guidelines: Minimum Information for Publication of Quantitative Digital PCR Experiments” (dMIQE) in 2013, there has been a large expansion of the applications of dPCR such as single nucleotide variations (SNVs) and copy number variations (CNVs) measurements associated with disease diagnostics.

What's Popular?

In Cancer

  1. JP Morgan Healthcare Day 3: Exact Sciences, NanoString, Natera, Horizon, Accelerate Dx, GenMark, More

  2. Imaging Mass Cytometry Uncovers Novel Breast Cancer Subgroups Associated With Outcomes

  3. Myriad Genetics Files for FDA Approval of BRACAnalysis CDx for Lynparza in Prostate Cancer

  4. JP Morgan Healthcare Day 2: 10x Genomics, GenapSys, Caris, Adaptive Bio, Danaher, Agilent, Luminex

  5. Illumina Targets Single-Cell, Oncology Applications With New NextSeq Platform

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © [current-date:custom:Y] GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.